Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-008418
Filing Date
2021-08-25
Accepted
2021-08-25 17:54:39
Documents
1
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3074
  Complete submission text file 0001179110-21-008418.txt   4621
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Issuer) CIK: 0001159036 (see all company filings)

EIN.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 235 LAUREL LN HAVERFOLD PA 19041
Business Address
BIZZARI JEAN-PIERRE (Reporting) CIK: 0001630914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32335 | Film No.: 211208055